Wolverine Asset Management LLC Supernus Pharmaceuticals, Inc. Put Options Transaction History

Wolverine Asset Management LLC

  • $4.35 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$20.2 - $25.05 $292,900 - $363,225
-14,500 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$17.09 - $24.89 $213,625 - $311,125
-12,500 Reduced 46.3%
14,500 $344,000
Q1 2020

May 13, 2020
BUY
$14.45 - $24.69 $197,965 - $338,253
13,700 Added 103.01%
27,000 $485,000
Q4 2019

Feb 14, 2020
BUY
$19.93 - $29.13 $265,069 - $387,429
13,300 New
13,300 $315,000

Others Institutions Holding SUPN

# of Institutions
282
Shares Held
60.9M
Call Options Held
27.7K
Put Options Held
11.3K
View Full List

About SUPERNUS PHARMACEUTICALS, INC.

SUPN Quotes by TradingView
  • Ticker SUPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 53,495,300
  • Market Cap $1.93B
  • Description
  • Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...
More about SUPN
Track This Portfolio

Track Wolverine Asset Management LLC Portfolio

Follow Wolverine Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email